Benitec Biopharma Inc. (BNTC)
NASDAQ·Healthcare·Biotechnology
$12.28
-2.62%
Mkt Cap $324.68M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | — | — | — | -$0.23 | -$0.26 | -13.04% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.35 | -$0.22 | +37.14% | — | — |
| Q3 2025 Sep 22, 2025 | — | $556.00K | — | -$0.28 | -$0.42 | -50.00% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.36 | -$0.24 | +33.33% | — | — |
| Q1 2025 Feb 14, 2025 | — | — | — | -$1.00 | -$0.36 | +64.00% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.61 | -$0.48 | +21.31% | — | — |
| Q3 2024 Sep 26, 2024 | — | — | — | -$0.49 | -$1.32 | -169.39% | — | — |
| Q2 2024 May 13, 2024 | — | $3.89K | — | -$0.78 | -$1.64 | -110.26% | — | — |
| Q1 2024 Feb 13, 2024 | — | — | — | -$0.39 | -$2.64 | -576.92% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.51 | -$2.76 | -441.18% | — | — |
| Q3 2023 Sep 21, 2023 | — | $4.65K | — | -$3.23 | -$2.83 | +12.38% | — | — |
| Q2 2023 May 15, 2023 | — | $36.26K | — | -$0.20 | -$2.72 | -1260.00% | — | — |
| Q1 2023 Feb 13, 2023 | $10.00K | $9.57K | -4.33% | -$0.11 | -$3.40 | -2990.91% | — | — |
| Q4 2022 Nov 10, 2022 | $9.50K | $305.86K | +3119.62% | -$2.04 | -$7.99 | -291.67% | — | — |
| Q3 2022 Sep 2, 2022 | — | $25.00K | — | -$4.76 | -$10.54 | -121.43% | — | — |
| Q2 2022 May 16, 2022 | $52.36K | $36.01K | -31.23% | -$7.48 | -$6.80 | +9.09% | — | — |
| Q1 2022 Feb 14, 2022 | — | $18.12K | — | — | -$10.03 | — | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | — | -$10.54 | — | — | — |
| Q3 2021 Sep 20, 2021 | — | $1.50K | — | — | -$5.10 | — | — | — |
| Q2 2021 May 12, 2021 | — | $761 | — | — | -$2.66 | — | — | — |